NASDAQ

Gyre Therapeutics, Inc. (GYRE)

♥ 509 Thanks from members

Live price chart, market sentiment, and community perspectives for Gyre Therapeutics, Inc. (NASDAQ: GYRE).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiopharmaceuticalsFounder: Gyre Therapeutics LeadershipLeadership: Dr. Charles Liu (CEO)Leadership: Frank Sun (CFO)Holder: Beijing Continent PharmaceuticalsHolder: Institutional FundsFaldaprevirPirfenidone AnalogsAnti-Fibrotic Therapeutics#GYRE#Gyre Therapeutics#NASDAQ GYRE#Biopharma Stock#Fibrosis Therapeutics